自身免疫生态学因素在自身免疫性肝炎发病机制中的作用

陈杰; 黄春洋; 单晶; 刘燕敏

doi:10.3969/j.issn.1001-5256.2019.10.046

自身免疫生态学因素在自身免疫性肝炎发病机制中的作用

DOI: 10.3969/j.issn.1001-5256.2019.10.046

首都医科大学附属北京佑安医院肝病免疫科

基金项目:

北京市属医院科研培育计划(PX2019062)；首都卫生发展科研专项青年项目(首发2014-4-2183)；丰台区卫生系统科研项目(2016-62)；

详细信息

中图分类号: R575.1
计量
- 文章访问数: 1159
- HTML全文浏览量: 50
- PDF下载量: 242
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-27
- 出版日期: 2019-10-20

Role of autoimmune ecological factors in the pathogenesis of autoimmune hepatitis

Department of Hepatology and Immunology,Beijing YouAn Hospital,Capital Medical University

Research funding:

摘要

摘要: 自身免疫性肝炎(AIH)是一种病因未明的慢性肝脏炎症性疾病,目前认为遗传和环境因素都参与AIH的发生。环境暴露对AIH发病的影响是至关重要的。自身免疫生态学是研究个体与环境之间的相互作用,以及个体与环境之间失平衡的发生及对自身免疫性疾病发展的促进机制的学科。就近年来自身免疫生态学在AIH发病机理研究进展作一综述。
- 肝炎,自身免疫性 /
- 环境暴露 /
- 生态学
Abstract: Autoimmune hepatitis(AIH) is a chronic liver inflammatory disease with unknown etiology,and at present,both genetic and environmental factors are thought to be involved in the pathogenesis of AIH. Environmental exposure has an important impact on the development of AIH. Autoimmune ecology is the study of the interactions between individuals and their environment,the development of imbalance between individuals and environment,and the mechanism of such imbalance in promoting the development of autoimmune disease. This article reviews the research advances in the role of autoimmune ecology in the pathogenesis of AIH.
- hepatitis,autoimmune /
- enviromental exposure /
- ecologys

HTML全文

参考文献(26)

[1] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medicalassociation; Chinese Society of Infectious Diseases,Chinese Medical Association. Chinese consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol,2016,32(1):9-22.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识(2015)[J].临床肝胆病杂志,2016,32(1):9-22.

[2] ANAYA JM,RAMIREZ-SANTANA C,ALZATE MA,et al. The auto immune ecology[J]. Front Immunol,2016,7:139.

[3] DOHERTY DG. Immunity,tolerance and autoimmunity in the liver:A comprehensive review[J]. J Autoimmun,2016,66:60-75.

[4] CHOI J,SELMI C,LEUNG PS,et al. Chemokine and chemokine receptors in autoimmunity:The case of primary biliary cholangitis[J]. Expet Rev Clin Immunol,2016,12(6):661-672.

[5] RIAZ A,ILAN N,VLODAVSKY I,et al. Characterization of heparinase induced phosphatidylinositol 3-kinase-AKT activation and its integrin dependence[J]. J Biol Chem,2013,288(17):12366-12375.

[6] ADEOYE GO,ALIMBA CG,OYELEKE OB. The genotoxicity and systemic toxicity of a pharmaceutical effluent in Wistar rats may involve oxidative stress induction[J]. Toxicology Reports,2015,2:1265-1272.

[7] ARNDTZ K,HIRSCHFIELD GM. The pathogenesis of autoimmune liver disease[J]. Dig Dis,2016,34(4):327–333.

[8] CUSICK MF,LIBBEY JE,FUJINAMI RS. Molecular mimicry as a mechanism of autoimmune disease[J]. Clin Rev Allergy Immunol,2012,42(1):102-111.

[9] ANAYA JM,RESTREPO-JIMNEZ P,RAMREZ-SANTANA C. The autoimmune ecology:An update[J]. Curr Opin Rheumatol,2018,30(4):350-360.

[10] CHEN J,ZHANG J,HE QS. Role of Toll-like receptors in development and progression of nonalcoholic fatty liver disease[J]. J Clin Hepatol,2015,31(7):1153-1155.(in Chinese)陈杰,张晶,何秋水. Toll样受体在非酒精性脂肪性肝病发生发展中的作用[J].临床肝胆病杂志,2015,31(7):1153-1155.

[11] CZAJA AJ. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis[J]. World J Gastroenterol,2016,22(42):9257-9278.

[12] HUANG CY,CHEN J,LIU YM,et al. Role of intestinal flora in the development/progression and treatment of autoimmune liver diseases[J]. J Clin Hepatol,2019,35(1):52-54.(in Chinese)黄春洋,陈杰,刘燕敏,等.肠道菌群在自身免疫性肝病发生发展及治疗中的作用[J].临床肝胆病杂志,2019,35(1):52-54.

[13] LIN R,ZHOU L,ZHANG J,et al. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis[J].Int. J Clin Exp Pathol,2015,8(5):5153-5160.

[14] VENTO S,GAROFANO T,DI PERRI G,et al. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitistype 1 in susceptible individuals[J]. Lancet,1991,337(8751):1183-1187.

[15] FLOREANI A,RESTREPO-JIMNEZ P,SECCHI MF,et al.Etiopathogenesis of autoimmune hepatitis[J]. J Autoimmun,2018,95(12):133-143.

[16] VERGANI D,MIELI-VERGANI G. Autoimmune manifestations in viral hepatitis[J]. Semin Immunopathol,2013,35(1):73-85.

[17] BADIANI RG,BECKER V,PEREZ RM,et al. Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis?[J]. World J Gastroenterol,2010,16(29):3704-3708.

[18] TAUBERT R,DIESTELHORST J,JUNGE N,et al. Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis[J]. Sci Rep,2018,8(1):17452.

[19] PAIARDINI A,PASCARELLA S. Structural mimicry between SLA/LP and Rickettsia surface antigens as a driver of autoimmune hepatitis:Insights from an in silico study[J]. Theor Biol Med Model,2013,10(3):25.

[20] TUNCCAN OG,TUFAN A,TELLI G,et al. Visceral leishmaniasis mimicking autoimmune hepatitis,primary biliary cirrhosis,and systemic lupus erythematosus overlap[J]. Korean J Parasitol,2012,50(2):133-136.

[21] THIELE GM,DURYEE MJ,WILLIS MS,et al,Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites[J]. Alcohol Clin Exp Res,2010,34(12):2126-2136.

[22] COLOTTA F,JANSSON B,BONELLI F. Modulation of inflammatory and immune responses by vitamin D[J]. J Autoimmun,2017,85(12):78-97.

[23] LUONG KV,NGUYEN LT. The role of vitamin D in autoimmune hepatitis[J]. J Clin Med Res,2013,5(6):407-415.

[24] EFE C,KAV T,AYDIN C,et al. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis[J].Dig Dis Sci,2014,59(12):3035-3042.

[25] HE Y,ZHAN J. Advances in drug-induced autoimmune hepatitis[J]. J Prac Hepatol,2013,16(2):178-180.(in Chinese)何艳,詹俊.药物诱导的自身免疫性肝炎研究进展[J].实用肝脏病杂志,2013,16(2):178-180.

[26] DELEMOS AS,FOUREAU DM,JACOBS C,et al. Drug-induced liver injury with autoimmune features[J]. Semin Liver Dis,2014,34(2):194-204.

施引文献

资源附件(0)

访问统计